Fabian P S Yu Selected Research

Farber Lipogranulomatosis

10/2019	Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency.
1/2018	Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.
1/2018	Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.
1/2018	Acid ceramidase deficiency: Farber disease and SMA-PME.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabian P S Yu Research Topics

Disease

4	Farber Lipogranulomatosis 10/2019 - 01/2018
3	Inflammation (Inflammations) 01/2019 - 01/2018
1	Vision Disorders (Hemeralopia) 01/2019
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2018
1	Lung Injury 01/2018
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2018
1	Edema (Dropsy) 01/2018

Drug/Important Bio-Agent (IBA)

4	Acid CeramidaseIBA 10/2019 - 01/2018
2	Lysergic Acid Diethylamide (LSD)IBA 10/2019 - 01/2018
2	SphingolipidsIBA 01/2019 - 01/2018
1	CeramidesIBA 10/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	CytokinesIBA 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Surface-Active Agents (Surfactants)IBA 01/2018